JPS5940143B2 - ペプチド組成物の製法 - Google Patents

ペプチド組成物の製法

Info

Publication number
JPS5940143B2
JPS5940143B2 JP50090023A JP9002375A JPS5940143B2 JP S5940143 B2 JPS5940143 B2 JP S5940143B2 JP 50090023 A JP50090023 A JP 50090023A JP 9002375 A JP9002375 A JP 9002375A JP S5940143 B2 JPS5940143 B2 JP S5940143B2
Authority
JP
Japan
Prior art keywords
octapeptide
solution
vial
met
sodium chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50090023A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5141356A (en, 2012
Inventor
エイ オンデツテイ ミゲ−ル
ルビン バ−ナ−ド
リフキン チヤ−ルズ
エル ウワイス ア−ロン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of JPS5141356A publication Critical patent/JPS5141356A/ja
Publication of JPS5940143B2 publication Critical patent/JPS5940143B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP50090023A 1974-07-22 1975-07-22 ペプチド組成物の製法 Expired JPS5940143B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/490,644 US3937819A (en) 1974-07-22 1974-07-22 Method of stabilizing an injectable composition of a cholecystokinin active octapeptide
US490644 1983-05-02

Publications (2)

Publication Number Publication Date
JPS5141356A JPS5141356A (en, 2012) 1976-04-07
JPS5940143B2 true JPS5940143B2 (ja) 1984-09-28

Family

ID=23948914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50090023A Expired JPS5940143B2 (ja) 1974-07-22 1975-07-22 ペプチド組成物の製法

Country Status (10)

Country Link
US (1) US3937819A (en, 2012)
JP (1) JPS5940143B2 (en, 2012)
BE (1) BE835289A (en, 2012)
CA (1) CA1054940A (en, 2012)
CH (1) CH607919A5 (en, 2012)
DE (1) DE2532740A1 (en, 2012)
DK (1) DK155777C (en, 2012)
FR (1) FR2279417A1 (en, 2012)
GB (1) GB1499029A (en, 2012)
SE (1) SE7508308L (en, 2012)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3061586D1 (en) * 1979-04-30 1983-02-17 Max Planck Gesellschaft Pancreozymin-cholezystokinin active peptides, process for their preparation and pharmaceutical compositions containing them
JPS5822474B2 (ja) * 1980-06-10 1983-05-09 天野製薬株式会社 コレシストキニン・パンクレオザイミンｃ端ペプチドアミドスルフエ−トエステルの製造法
US4400377A (en) * 1980-09-26 1983-08-23 Farmitalia Carlo Erba, S.P.A. Use of polypeptides as analgesic drugs
US4351829A (en) * 1980-09-26 1982-09-28 Farmitalia Carlo Erba Spa Use of polypeptides as analgesic drugs
JPS61172878A (ja) * 1985-01-28 1986-08-04 Sankyo Co Ltd カルバペネム誘導体の安定な凍結乾燥製剤の製法
US5495851A (en) * 1995-03-23 1996-03-05 Roanoke Gastroenterology, P.C. Use of endoscopic ultrasound and stimulated bilary drainage in the diagnosis of cholecystitis and microlithiasis
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
US7690395B2 (en) * 2004-01-12 2010-04-06 Masco Corporation Of Indiana Multi-mode hands free automatic faucet
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3734946A (en) * 1969-12-23 1973-05-22 Squibb & Sons Inc Serine derivatives
US3723406A (en) * 1969-12-23 1973-03-27 Squibb & Sons Inc Novel peptides having cholecystokinin activity and intermediates therefor

Also Published As

Publication number Publication date
DK155777C (da) 1989-10-30
CA1054940A (en) 1979-05-22
DE2532740A1 (de) 1976-02-12
US3937819A (en) 1976-02-10
CH607919A5 (en, 2012) 1978-12-15
SE7508308L (sv) 1976-01-23
FR2279417B1 (en, 2012) 1978-11-10
GB1499029A (en) 1978-01-25
DK330575A (da) 1976-01-23
JPS5141356A (en, 2012) 1976-04-07
DK155777B (da) 1989-05-16
FR2279417A1 (fr) 1976-02-20
BE835289A (fr) 1976-05-05

Similar Documents

Publication Publication Date Title
US5652216A (en) Pharmaceutical preparation
JPH0341033A (ja) 安定なモチリン類含有製剤
ES2405994T3 (es) Soluciones estabilizadas de teriparatide
JP3530300B2 (ja) 安定なトランスグルタミナーゼ製剤およびそれらを製造する方法
US20170014470A1 (en) Sincalide Formulations
JP7229999B2 (ja) ダプトマイシン製剤
HU202761B (en) Process for producing stabilized erythropoietin compositions
US11865180B2 (en) Levothyroxine formulations for oral use
JPS5940143B2 (ja) ペプチド組成物の製法
EP0215596A2 (en) Composition for injection of active type vitamins D3
JP2012167132A (ja) Ｎ−［ｏ−（ｐ−ピバロイルオキシベンゼンスルホニルアミノ）ベンゾイル］グリシン・モノナトリウム塩・４水和物の凍結乾燥製剤
JP3927954B2 (ja) カンプトテシン誘導体含有水性製剤およびそれを凍結乾燥した医薬組成物
US3940480A (en) Process for production of stabilized powdery secretin preparation by lyophilization
US20090163421A1 (en) Room Temperature Stable, Lyophilized Natriuretic Peptide Formulations
BRPI0612745A2 (pt) composições farmacêuticas estáveis, tamponadas que incluem peptìdeos tipo motilina
RU2134112C1 (ru) Стабильная лиофилизированная композиция тиотепа и способ ее получения
ES2342833T3 (es) Formulacion liofilizada estabilizada, para derivados de cefalosporina.
JP4564652B2 (ja) ０．５ｍｌ未満の容量を投与するための凍結乾燥タンパク質組成物を含む１回量注射器
GB2221907A (en) Superoxide dismutase composition.
EP0189673A1 (en) Stable growth hormone releasing factor preparation
US4966899A (en) Antibacterial lyophilized preparation of aspoxicillin
BRPI0613707A2 (pt) composições farmacêuticas estáveis incluindo peptìdeos similares à motilina
KR930004600B1 (ko) γ-인터페론 조성물의 제조방법
JP7630625B2 (ja) 改善された凍結乾燥製剤
JPH0341032A (ja) モチリン類含有水溶液